The feedback vacuum
The most common reason people stop is the simplest: nothing happens that they can feel. NMN is not a stimulant. Its proposed benefits are slow, systemic and largely invisible from the inside.
Habits survive on reinforcement. Caffeine reinforces immediately; a gym session reinforces within weeks. A supplement whose entire value proposition is a biomarker you are not measuring has no reinforcement loop at all, and eventually the bottle runs out and does not get reordered.
This applies to every longevity supplement including ours, which is exactly why we recommend measuring. A panel result is the only feedback loop this category can honestly offer.
Cost without a horizon
Quality NMN at a meaningful dose is a real monthly line item, and unlike a course of anything, there is no defined endpoint. The implied commitment is indefinite.
At some point most people run the arithmetic on annual spend and ask what they got. Without measurement the honest answer is "I do not know" — and "I do not know" rarely survives a budget review.
The regulatory rupture
In 2022 the FDA took the position that NMN was excluded from the dietary-supplement definition, having been investigated as a drug. Major retailers delisted, supply became erratic, and buyers who had built a multi-year routine suddenly could not reliably reorder.
The situation has been contested since and remains unsettled. For a consumer the practical effect is the same regardless of who is right: uncertainty about whether the product will exist next year is corrosive to a habit meant to run for a decade.
The UK’s novel-foods framework created a parallel problem for British buyers, which is a large part of why UK search volume for alternatives is what it is.
Quality variance
Third-party testing of NMN products has repeatedly found actual content diverging from label claims, sometimes severely. For a compound that is expensive to synthesise properly, this is a predictable outcome in a market with light enforcement.
The consequence is a buyer paying premium prices with no way to verify what is in the capsule — which for a category asking people to trust invisible mechanisms is corrosive in a way that is hard to recover from.
What people move to
The common paths after NMN: stopping entirely, often the rational choice if nothing was being measured; switching to NR, a related precursor with a clearer regulatory position; moving to a different mechanism such as autophagy or oxidative-defence approaches; or stacking, adding rather than replacing.
If you are in this position, the useful move is not picking the next bottle. It is deciding what you would measure, and what result would make you stop. That question is more valuable than any product recommendation, including ours.